BNET Industries
Market Cap:$143.3B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
CORRECTING and REPLACING Pfizer And Crown Bioscience Announce A Collaboration To Research And...
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Pfizer and B.C. launch $9M collaboration to tackle cancer
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Pfizer signs agreement with Protalix BioTherapeutics for Taliglucerase alfa
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Conservationists salute two corporations
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
2009: The Year That Was For Pfizer
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
-
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24
-
ImmunoVaccine signs exclusive licence deal with Pfizer
-
Pfizer Animal Health selects Bader Rutter as agency of record
News & Analysis
Filter by
pfizer inc. and pharmaceutical company - All News and Analysis
Why Pfizer's Deal with Protalix Is Bad News for Big Pharma Sales Reps
BNET
- 2009-12-01
Pfizer's partnership with Protalix BioTherapeutics for Gaucher's disease drug Uplyso taliglucerase alfa offers one more piece of evidence that the days of traditional big pharma sales reps are limited. by Trista Morrison
The 10 Weirdest Drug Stories of the Month
BNET
- 2009-05-01
April 2009 has come and gone, and once again it is time for BNET's roundup of the top 10 weirdest drug stories of the month. Enjoy! Bayer has a flock of sheep mow its lawn About 1450 sheep grazed Bayer's Richmond, Calif., campus last nonth, eating...
Pfizer, Vertex Execs Are Victims of Facebook Faker; Forbes, WSJ Also Targeted
BNET
- 2009-04-29
Someone is impersonating prominent members of the pharma and biotech world on Facebook, including Vertex Pharmaceuticals chief executive Joshua Boger, a chief science officer at Pfizer and Forbes drug writer Matt Herper. by Jim Edwards
Claim: LeCarre's "The Constant Gardener" Was Based on Pfizer Trovan Case
BNET
- 2009-02-17
The Connecticut Law Tribune claims that The Constant Gardener, a John Le Carré book and later a movie with the same name, is in fact based on the Pfizer Trovan case. But is the claim true? A look at the timeline of both the case and the book suggest it...
Waters Corp. Q4 FY08 Earnings Call
Seeking Alpha
- 2009-01-27
Question-and-Answer SessionOperator [Operator Instruction] Your first question comes from Ross Muken, Deutsche Bank. Your line is open. Ross Muken - Deutsche Bank Good morning, gentlemen. Douglas Berthiaume Good morning Ross. Ross Muken - Deutsche Bank Can you walk us through on the instrument side, sort...
Pharma Roundup: Lilly's Zyprexa Settlement; Cuts at Pfizer, Roche; and More
BNET
- 2009-01-15
Lilly's Zyprexa settlment is biggest ever; Pfizer may cut 2,400; Roche cuts 780; Novartis' Ebeling on the future of pharma. by John Maas
Pharma Roundup: Pfizer's Acquisition Plans, Prasugrel's Big Day, and More
BNET
- 2009-01-05
Pfizer wants acquisitions, big and small. Prasugrel has a date with the FDA. New Year's blog feature bonanza. Farewell, Pharmalot. by John Maas
Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth
BNET
- 2009-01-05
New Year is a slow news period, which is why the business press filled up with next-to-useless corporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....
Pharma Roundup: AstraZeneca and Teva Mend Fences, Barbara Ryan's M&A Speculation, and More
BNET
- 2008-11-25
AstraZeneca and Teva settle a potentially-acrimonious patent battle. Barbara Ryan speculates on pharma M&A. EU criticizes "strategic patenting." Indonesia wants drug production facilities from Big Pharma. by John Maas
Pharma Roundup: Amylin Cuts Jobs, Sanofi Faces Hard Times, and More
BNET
- 2008-11-11
Amylin cuts 340 jobs, UBS predicts hard times for Sanofi, Pfizer sells a factory and GSK will close one. by John Maas
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
Presented by the Premiere Rewards Gold Card from American Express